Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mad2 who wrote (558)	5/9/1999 8:51:00 AM
From: DanZ	Read Replies (1) \| Respond to of 5582

Mad2, <do you have any published source or filing where you got the information that Gel Tech LLC owns the tradename and intellectual property on Zicam.> GumTech's 10K that you quoted from contains the following statement: The Company and Gel Tech will contribute certain intellectual property rights relating to the product. While this statement doesn't say how much each contributed, I called GumTech and they told me that each company contributed all their intellectual property rights to Zicam. <I'm trying to understand who owns the patent for Zinullose and any other property rights. If so what are the financial and other terms.> Gel Tech LLC owns 100% of the intellectual property rights to Zicam, including the patent for Zinullose. What sort of financial terms are you looking for? GumTech noted in the 10K that they will provide Gel Tech LLC a loan in the amount of $3.5 million. From the 10K: The Operating Agreement will contain the specific terms of operation of the LLC and the duties and responsibilities of the Company and Gel Tech. GumTech will be filing an 8K soon. Hopefully it will contain details from the operating agreement or a copy of the operating agreement itself. In the meantime, I'm sure if you call GumTech they will answer any questions that they can. Best regards, Dan